Oxford-AstraZeneca vaccine to be trialed on children for first time

LONDON – The University of Oxford announced on Saturday that it would test the effects of its Covid-19 vaccine on children. With this she will be the first developer to test whether the coronavirus shot is effective in young people.

The study will assess the “safety and immune responses” in children and young adults between the ages of 6 and 17 years of the vaccine, which she developed with the pharmaceutical company AstraZeneca Explanation.

The study, which will be attended by 300 volunteers, will take place in three English cities, London, Southampton and Bristol. The first vaccinations are expected later in February.

“While most children are relatively unaffected by coronavirus and are unlikely to be uncomfortable with the infection, establishing the safety and immune response to the vaccine in children and adolescents is important as some children may benefit from vaccination,” said professor Andrew Pollard, lead investigator for the Oxford vaccine study.

The two-dose Oxford-AstraZeneca vaccine is cheaper and easier to distribute than some of its competitors.

AstraZeneca aims to produce 3 billion cans this year and has won multiple orders from countries such as the US, Canada, Japan and Brazil, and the UK.

The UK has the deadliest coronavirus outbreak in Europe, with more than 116,000 deaths, and is in its third national lockdown as authorities try to contain new, more transmissible variants of the virus. Most schools are also closed.

In the past few weeks there have been concerns about the vaccine’s effectiveness against global mutations, particularly a variant discovered in South Africa.

The UK also announced earlier this month that it would try to mix up vaccinations. Patients receive different vaccines for their first and second dose: either the Oxford-AstraZeneca shot, followed by the Pfizer and BioNTech vaccine, or vice versa.

Britain has campaigned for its public vaccination efforts 14 million people Of the population of around 66 million, they have so far received their first dose of vaccine.

Download the NBC News App for full coverage of the coronavirus outbreak

According to the University of Oxford, Israel and the United Arab Emirates are far ahead of the United States and the European Union, among others global vaccination tracker website.

More than 2 million people According to the Johns Hopkins University, the coronavirus has died worldwide.

Reuters contributed to this report.

Leave a Comment